.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Thermo Fisher Scientific recently announced a major microbiology business sale to private equity firm Astorg. This deal carries a value of approximately $1.08 billion. Consequently, the transaction includes cash and a $50 million seller note. This specific unit provides antimicrobial susceptibility testing and culture media products. These tools are essential for clinical, pharmaceutical, and food safety applications.
The unit belongs to the specialty diagnostics segment at Thermo Fisher. Furthermore, it generated $645 million in revenue during 2025. This divestiture allows the company to manage its portfolio more actively. Therefore, they can deploy capital to create higher shareholder value. However, the transaction will likely reduce adjusted earnings initially. Specifically, the company expects a $0.15 impact per share in the first full year after the close.
The company expects the sale to close in the second half of 2026. Consequently, medical professionals in India should monitor potential changes in product availability. Astorg is a well-known private equity firm with a history of scaling healthcare assets. Thus, this transition might lead to new investments in the microbiology sector. Additionally, Thermo Fisher will provide more financial details during their next earnings call.
Q1: What does the Thermo Fisher microbiology business produce?
The unit supplies antimicrobial susceptibility testing and culture media products used in clinical, pharmaceutical, and food safety settings.
Q2: When will the transaction between Thermo Fisher and Astorg be finalized?
The companies expect the deal to close during the second half of 2026, pending regulatory approvals.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Thermo Fisher Scientific is selling its microbiology business to Astorg for $1.08 billion to focus on specialty diagnostics and shareholder value....
2 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
